TFF Pharmaceuticals, Inc. (TFFP)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading TFF Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for TFF Pharmaceuticals, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

5

Exchange

Nasdaq

$0M

Total Revenue

5

Employees

$7M

Market Capitalization

-0.76

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TFFP News

TFFP TFF Pharmaceuticals, Inc.

3d ago, source: Seeking Alpha

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in ...

TFF Pharmaceuticals (TFFP) Price Target Decreased by 28.99% to 24.99

8d ago, source: Fintel on MSN

The average one-year price target for TFF Pharmaceuticals (NasdaqCM:TFFP) has been revised to 24.99 / share. This is an decrease of 28.99% from the prior estimate of 35.19 dated March 28, 2024. The ...

TFF Pharmaceuticals Inc Ordinary Shares

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

28d ago, source: Business Insider

FORT WORTH, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and ...

TFF Pharmaceuticals, Inc. (TFFP)

9d ago, source: Yahoo Finance

Compa FORT WORTH, Texas, Jan. 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative ...

TFF Pharmaceuticals Inc Ordinary Shares

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

27d ago, source: Finanznachrichten

TFF PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 5,478,113 $ 16,612,315 Research and development tax incentive ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...